The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo

od Ma, Jingui, Xin, Xianliang, Meng, Linghua, Tong, Linjiang, Lin, Liping, Geng, Meiyu, Ding, Jian
Izdano 2008

Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors

od Lv, Yongcong, Li, Mengyuan, Liu, Ting, Tong, Linjiang, Peng, Ting, Wei, Lixin, Ding, Jian, Xie, Hua, Duan, Wenhu
Izdano 2014

Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors

od Hu, Xiuqin, Wang, Disha, Tong, Yi, Tong, Linjiang, Wang, Xia, Zhu, Lili, Xie, Hua, Li, Shiliang, Yang, You, Xu, Yufang
izdano v Front Chem (2017)

Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs

od Chen, Yun, Ning, Yi, Bai, Gang, Tong, Linjiang, Zhang, Tao, Zhou, Jinpei, Zhang, Huibin, Xie, Hua, Ding, Jian, Duan, Wenhu
izdano v ACS Med Chem Lett (2020)

AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR

od Zhou, Yuanfeng, Chen, Yi, Tong, Linjiang, Xie, Hua, Wen, Weiwei, Zhang, Jie, Xi, Yong, Shen, Yanyan, Geng, Meiyu, Wang, Yuanyuan, Jiang, Hualiang, Luo, Cheng, Lin, Liping, Ding, Jian
Izdano 2012

Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR(L858R/T790M/C797S)

od Li, Qiannan, Zhang, Tao, Li, Shiliang, Tong, Linjiang, Li, Junyu, Su, Zhicheng, Feng, Fang, Sun, Deheng, Tong, Yi, Wang, Xia, Zhao, Zhenjiang, Zhu, Lili, Ding, Jian, Li, Honglin, Xie, Hua, Xu, Yufang
izdano v ACS Med Chem Lett (2019)

AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo

od Xie, Hua, Lin, Liping, Tong, Linjiang, Jiang, Yong, Zheng, Mingyue, Chen, Zhuo, Jiang, Xiaoyan, Zhang, Xiaowei, Ren, Xiaowei, Qu, Wenchao, Yang, Yang, Wan, Hua, Chen, Yi, Zuo, Jianping, Jiang, Hualiang, Geng, Meiyu, Ding, Jian
Izdano 2011

Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimization

od Kong, Xiangqian, Qin, Jie, Li, Zeng, Vultur, Adina, Tong, Linjiang, Feng, Enguang, Rajan, Geena, Liu, Shien, Lu, Junyan, Liang, Zhongjie, Zheng, Mingyue, Zhu, Weiliang, Jiang, Hualiang, Herlyn, Meenhard, Liu, Hong, Marmorstein, Ronen, Luo, Cheng
Izdano 2012

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

od Zhang, Tao, Qu, Rong, Chan, Shingpan, Lai, Mengzhen, Tong, Linjiang, Feng, Fang, Chen, Hongyu, Song, Tingting, Song, Peiran, Bai, Gang, Liu, Yingqiang, Wang, Yanan, Li, Yan, Su, Yi, Shen, Yanyan, Sun, Yiming, Chen, Yi, Geng, Meiyu, Ding, Ke, Ding, Jian, Xie, Hua
izdano v Mol Cancer (2020)